Seneca Biopharma, Inc.
(NASDAQ : CUR)

( )
CUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.34%74.350.0%$2403.57m
NVAXNovavax, Inc. 3.41%176.1099.2%$1260.45m
SRNESorrento Therapeutics, Inc. 8.95%15.711.8%$652.23m
GILDGilead Sciences, Inc. -0.40%69.071.0%$556.88m
AMGNAmgen, Inc. -0.08%240.501.3%$476.23m
REGNRegeneron Pharmaceuticals, Inc. -0.36%618.002.5%$427.98m
BNTXBioNTech SE 1.30%78.000.0%$404.75m
VRTXVertex Pharmaceuticals, Inc. 0.00%272.991.9%$368.45m
BIIBBiogen, Inc. 0.91%308.501.6%$364.36m
ILMNIllumina, Inc. 0.38%357.013.5%$338.10m
VXRTVaxart, Inc. 2.29%9.400.0%$287.41m
EBSEmergent BioSolutions, Inc. 0.00%130.666.4%$180.62m
IBIOiBio, Inc. 10.82%4.200.2%$175.66m
ALXNAlexion Pharmaceuticals, Inc. -0.11%103.172.0%$166.42m
SGENSeattle Genetics, Inc. -0.83%160.456.0%$163.01m

Company Profile

Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.